Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Here’s Greenlight Capital’s Update on Coya Therapeutics (COYA)

Greenlight Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Greenlight Capital funds returned -3.6% in the quarter, net of fees and expenses, compared to 8.1% for the S&P 500 index. The fund returned 0.4% in YTD compared to 14.8% for the index. For more information on the fund’s top picks in 2025, please check its top five holdings.

In its third-quarter 2025 investor letter, Greenlight Capital highlighted stocks such as Coya Therapeutics, Inc. (NASDAQ:COYA). Coya Therapeutics, Inc. (NASDAQ:COYA)...